SFPG
OGN icon

Stonebridge Financial Planning Group’s Organon & Co OGN Stock Holding History

Stonebridge Financial Planning Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-75
Closed -$2K – 279
2021
Q4 		$2K Hold
75
– – ﹤0.01% 390
2021
Q3 		$3K Hold
75
– – ﹤0.01% 391
2021
Q2 		$2K Buy
+75
New +$2.47K ﹤0.01% 403

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stonebridge Financial Planning Group's OGN Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 75 shares — an estimated $2K sold.

Stonebridge Financial Planning Group first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $3K in Q3 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Stonebridge Financial Planning Group reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 75 Organon & Co shares in Q1 2022, an estimated $2K.
  • Stonebridge Financial Planning Group first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Stonebridge Financial Planning Group's Organon & Co position peaked at $3K in Q3 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.